G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 27 filers reported holding G1 THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $49,646,000 | +63.3% | 949,431 | +35.7% | 1.33% | +156.2% |
| Q2 2018 | $30,397,000 | +17.3% | 699,431 | 0.0% | 0.52% | +13.3% |
| Q1 2018 | $25,914,000 | +190.3% | 699,431 | +55.4% | 0.46% | +200.7% |
| Q4 2017 | $8,928,000 | -20.3% | 450,000 | 0.0% | 0.15% | -17.8% |
| Q3 2017 | $11,201,000 | +42.7% | 450,000 | 0.0% | 0.18% | +52.9% |
| Q2 2017 | $7,848,000 | – | 450,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |